Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-24 @ 9:32 PM
NCT ID:
NCT04428632
Brief Summary:
This expanded access program will provide access to berotralstat for eligible participants with hereditary angioedema in the U.S.
Detailed Description:
Physicians may request access to berotralstat for eligible participants with unmet medical need
Physicians can send email inquiries to access.us@inceptua.com or call 1-888-225-8677
Patients who may be interested should contact their physician about participation
Berotralstat (BCX7353) will be available through this expanded access program until it is commercially available
Study:
NCT04428632
Study Brief:
Protocol Section:
NCT04428632